Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
Clinical trial NCT06818474 · RECRUITING
Trial details
- NCT number
- NCT06818474
- Sponsor
- Bernstein Clinical Research Center
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2027-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.